The prognostic strength of serum LDH and serum ferritin in children with neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project.

MLA

Moroz, Veronica, et al. “The Prognostic Strength of Serum LDH and Serum Ferritin in Children with Neuroblastoma: A Report from the International Neuroblastoma Risk Group (INRG) Project.” Pediatric Blood & Cancer, vol. 67, no. 8, Aug. 2020, p. e28359. EBSCOhost, https://doi.org/10.1002/pbc.28359.

APA

Moroz, V., Machin, D., Hero, B., Ladenstein, R., Berthold, F., Kao, P., Obeng, Y., Pearson, A. D. J., Cohn, S. L., & London, W. B. (2020). The prognostic strength of serum LDH and serum ferritin in children with neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project. Pediatric Blood & Cancer, 67(8), e28359. https://doi.org/10.1002/pbc.28359

Chicago

Moroz, Veronica, David Machin, Barbara Hero, Ruth Ladenstein, Frank Berthold, Paige Kao, Yaa Obeng, Andrew D J Pearson, Susan L Cohn, and Wendy B London. 2020. “The Prognostic Strength of Serum LDH and Serum Ferritin in Children with Neuroblastoma: A Report from the International Neuroblastoma Risk Group (INRG) Project.” Pediatric Blood & Cancer 67 (8): e28359. doi:10.1002/pbc.28359.